James A. Geraghty

James A. Geraghty

DirectoratFulcrum Therapeutics· In proxies 2023–2025

James A. Geraghty sits on 10 public boards.

Boards2

  • Voyager TherapeuticsDirector · 9 yr on the boardIndependentAudit (Chair), Nominating and Corporate Governance (Chair)—Paid as an executive
  • Fulcrum TherapeuticsDirector · 7 yr on the boardIndependentAudit, Nominating and Corporate Governance (Chair)—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Fulcrum TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -38%
  2. Voyager TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. Voyager Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  4. Aceragen Inc.Public company
    • Director? – PresentNo stock prices for these years
  5. Palvella Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  6. OMass TherapeuticsPublic company · 3 yr
    • Director2023 – 2026 · 3 yrNo stock prices for these years
  7. Pieris PharmaceuticalsPublic company · 7 yr
    • Director2017 – 2024 · 7 yrNo stock prices for these years
  8. Orchard TherapeuticsPublic company · 4 yr
    • Director2020 – 2024 · 4 yrNo stock prices for these years
  9. Idera PharmaceuticalsPublic company · 10 yr
    • Director2013 – 2023 · 10 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?